With maturity comes confidence: EBCTCG tamoxifen update

The Lancet

Volumn 378, Issue 9793, 2011, Pages 747-749

  Chia, Stephen K ^a   Wolff, Antonio C ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; ESTROGEN RECEPTOR; PLACEBO; TAMOXIFEN;

ADJUVANT THERAPY; BREAST CANCER; CANCER MORTALITY; CANCER STAGING; CLINICAL TRIAL (TOPIC); DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; LIFE EXPECTANCY; MATURITY; META ANALYSIS (TOPIC); NOTE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENCE RISK;

EID: 80052260611     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)61128-8     Document Type: Letter

References (17)

1. Early Breast Cancer Trialists' Collaborative Group Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials Lancet 2011 10.1016/S0140-6736(11)60993-8 published online July 29.
2. A Jemal, F Bray, MM Center, J Ferlay, E Ward, D Forman Global cancer statistics CA Cancer J Clin 61 2011 61 90
3. Social Security Online Period life table 2007 http://www.ssa.gov/oact/ STATS/table4c6.html (accessed June 20, 2011).
4. HJ Burstein, AA Prestrud, J Seidenfeld et al. American Society of Clinical Oncology clinical practice guideline: update of adjuvant endocrine therapy for women with hormone receptor-positive breast cancer J Clin Oncol 28 2010 3784 3796
5. J Cuzick, I Sestak, M Baum et al. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial Lancet Oncol 11 2010 1135 1141
6. M Dowsett, J Cuzick, J Ingle et al. Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen J Clin Oncol 28 2009 509 518
7. A Hackshaw, M Roughton, S Forsyth et al. Long-term benefits of 5 years of tamoxifen: 10 year follow-up of a large randomized trial in women at least 50 years of age with early breast cancer J Clin Oncol 29 2011 1657 1663
8. B Nordenskhold, J Rosell, LE Rutqvist et al. Coronary heart disease mortality after 5 years of adjuvant tamoxifen therapy: results from a randomized trial J Natl Cancer Inst 97 2005 1609 1610 (Pubitemid 41662715)
9. AC Wolff, M Dowsett Estrogen receptor: a neverending story? J Clin Oncol 2011 10.1200/JCO.2011.35.4589 published online June 27.
10. KS Albain, WE Barlow, PM Ravdin et al. Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open label, randomised controlled trial Lancet 374 2009 2055 2063
11. MEH Hammond, DF Hayes, M Dowsett et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer J Clin Oncol 28 2010 2784 2795
12. MR Khoshnoud, B Lofdahl, H Fohlin et al. Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of long term effect of adjuvant tamoxifen Breast Cancer Res Treat 126 2011 421 430
13. JM Harvey, GM Clark, CK Osborne et al. Estrogen receptor status by immunochemistry is superior to the ligand binding assay for predicting response to adjuvant endocrine therapy in breast cancer J Clin Oncol 17 1999 1474 1481 (Pubitemid 29220854)
14. AW Welch, CB Moeder, S Kumar et al. Standardization of estrogen receptor measurement in breast cancer suggests false negative results are a function of threshold intensity rather than percentage of positive cells J Clin Oncol 2011 10.1200/JCO.2010.32.9706 published online June 27.
15. JJ Dignam, V Dukic, SJ Anderson et al. Hazard of recurrence and adjuvant treatment effects over time in lymph node negative breast cancer Breast Cancer Res Treat 116 2009 595 602
16. The BIG 1-98 Collaborative Group Letrozole alone or in sequence with tamoxifen in women with breast cancer N Engl J Med 361 2009 5715 5722
17. J Ferlay, HR Shin, F Bray, D Forman, C Mathers, DM Parkin GLOBOCAN 2008: cancer fact sheet http://globocan.iarc.fr/factsheets/cancers/all.asp (accessed July 1, 2011).